tiprankstipranks
Bright Minds Biosciences (TSE:DRUG)
CNQX:DRUG

Bright Minds Biosciences (DRUG) Ownership - Who Owns Bright Minds Biosciences?

6 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 05, 2024
Ian Mcdonald
President & Chief Executive Officer, >10% Owner
BoughtC$0
Aug 10, 2023
Jeremy Fryzuk
Non Executive,director
SoldC$22428

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,002,500Insider46.36%2,743,425
1,496,000Insider34.63%2,049,520
944,900Insider21.87%1,294,513
944,900Insider21.87%1,294,513
400,000Insider9.26%548,000
176,038Institution4.08%176,390
26,400Insider0.61%36,168

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
176,038Institution4.08%176,038

FAQ

Who Owns Bright Minds Biosciences (TSE:DRUG)?
Currently, no data Available
What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by institutional investors?
Currently, no data Available
What percentage of Bright Minds Biosciences (TSE:DRUG) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Bright Minds Biosciences (TSE:DRUG)?
Alan Kozikowski owns the most shares of Bright Minds Biosciences (TSE:DRUG).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis